The recent disruptions in global chains have highlighted the value of securing vital medications like Ivermectin. Relying on overseas producers exposes regions to significant vulnerabilities, including delivery delays, price fluctuations, and even geopolitical risks. Transitioning towards domestic production of Ivermectin offers a multitude of adva